Literature DB >> 16116833

Benign paroxysmal positional vertigo: a study of two manoeuvres with and without betahistine.

M Cavaliere1, G Mottola, M Iemma.   

Abstract

Efficacy of the liberatory manoeuvre and of gradual otolitis dispersion technique, with or without associated drug therapy, have been compared. Included in this prospective study were 103 patients with benign paroxysmal positional vertigo seen in the Outpatient Department. Patients were classified into 4 groups according to treatment: Liberatory Manoeuvre according to methods described by Semont et al., with and without betahistine, Gradual Otolitis Dispersion Technique according to Brandt and Daroff, with and without betahistine. Evaluation was performed at baseline and at 3, 7, 14, 30, 60 and 90 days after start of treatment. Response to treatment was evaluated using criteria of Epley. At day 14, liberatory manoeuvre-betahistine and Brandt and Daroff-betahistine groups did significantly better than liberatory manoeuvre and Brandt and Daroff groups (p < 0.05). Improvement reached at day 30 was: 100% in liberatory manoeuvre-betahistine group; 96.30% (p > 0.05) in Brandt and Daroff-betahistine group; these results were significantly better (p < 0.05) than those of liberatory manoeuvre (54.17%) and Brandt and Daroff (25%) groups. As far as concerns differences between disease onset and start of therapy (less and more than 2 weeks), and age (< or =60 years and > or =60 years), response to treatment was similar. In conclusion, both liberatory manoeuvre and Brandt and Daroff, when associated with betahistine, were significantly more effective than manoeuvres alone (p < 0.05). Improvement in liberatory manoeuvre-betahistine group, in the initial phase, was greater that in Brandt and Daroff-betahistine group, albeit, differences were not significant (p > 0.05). Age-related effects of manoeuvres were compared in 71 patients < 60 years and 32 patients > or =60 years, showing a similar improvement rate at the end of the investigation in both groups. In our opinion, liberatory manoeuvre and Brandt and Daroff associated with betahistamine produces faster recovery compared to liberatory manoeuvre and Brandt and Daroff alone. Nevertheless, 3 months after onset of treatment, all patients showed complete recovery due to spontaneous evolution of paroxysmal positional vertigo, in other words, treatment does not appear to influence the final improvement rate and its role should be accepted as a significant reduction in persistence of symptoms.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16116833      PMCID: PMC2639876     

Source DB:  PubMed          Journal:  Acta Otorhinolaryngol Ital        ISSN: 0392-100X            Impact factor:   2.124


  23 in total

1.  Clinical use of beta-2-pyridylalkylamines. I.

Authors:  B T HORTON; H VON LEDEN
Journal:  Proc Staff Meet Mayo Clin       Date:  1962-12-05

2.  Effect of histamine on intracellular Ca2+ concentration in guinea pig isolated vestibular hair cells.

Authors:  K Tomoda; M Nagata; N Harada; H Iwai; T Yamashita
Journal:  Acta Otolaryngol Suppl       Date:  1997

Review 3.  Physiopathology of H3-receptors and pharmacology of betahistine.

Authors:  P B Van Cauwenberge; S E De Moor
Journal:  Acta Otolaryngol Suppl       Date:  1997

4.  Curing the BPPV with a liberatory maneuver.

Authors:  A Semont; G Freyss; E Vitte
Journal:  Adv Otorhinolaryngol       Date:  1988

5.  Cupulolithiasis.

Authors:  H F Schuknecht
Journal:  Arch Otolaryngol       Date:  1969-12

6.  Betahistine, vestibular function and compensation: in vitro studies of vestibular function and plasticity.

Authors:  M B Dutia
Journal:  Acta Otolaryngol Suppl       Date:  2000

7.  Betahistine reduces the resting firing rate of vestibular receptors in the frog.

Authors:  P Valli
Journal:  Acta Otolaryngol Suppl       Date:  2000

Review 8.  Positional vertigo related to semicircular canalithiasis.

Authors:  J M Epley
Journal:  Otolaryngol Head Neck Surg       Date:  1995-01       Impact factor: 3.497

Review 9.  The dizzy patient.

Authors:  R W Baloh
Journal:  Postgrad Med       Date:  1999-02       Impact factor: 3.840

10.  Histamine and related substances influence neurotransmission in the semicircular canal.

Authors:  G D Housley; C H Norris; P S Guth
Journal:  Hear Res       Date:  1988-09-01       Impact factor: 3.208

View more
  8 in total

1.  Betahistine dihydrochloride with and without early vestibular rehabilitation for the management of patients with balance disorders following head trauma: a preliminary randomized clinical trial.

Authors:  Maged B Naguib; Yasser T Madian
Journal:  J Chiropr Med       Date:  2014-03

2.  Analysis of risk factors influencing the outcome of the Epley maneuver.

Authors:  E Domínguez-Durán; E Domènech-Vadillo; M G Álvarez-Morujo de Sande; R González-Aguado; G Guerra-Jiménez; Á Ramos-Macías; C Morales-Angulo; A J Martín-Mateos; E Figuerola-Massana; H Galera-Ruiz
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-07-19       Impact factor: 2.503

3.  High stimulus rate brainstem auditory evoked potential in benign paroxysmal positional vertigo.

Authors:  Juan-Wen He; Qiang Gong; Xue-Feng Wang; Zheng Xiao
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-07-09       Impact factor: 2.503

4.  Effects and safety profile of betahistine in patients in the Russian contingent of OSVaLD, an open-label observational study in vestibular vertigo.

Authors:  Svetlana Vyacheslavovna Morozova; Natalia Stepanovna Alekseeva; Sergey Vasilyevich Lilenko; Eduard Ivanovich Matsnev; Oleg Anatol'evich Melnikov
Journal:  Int J Gen Med       Date:  2015-01-22

5.  Effectiveness of betahistine (48 mg/day) in patients with vestibular vertigo during routine practice: The VIRTUOSO study.

Authors:  Vladimir A Parfenov; Volodymyr A Golyk; Eduard I Matsnev; Svetlana V Morozova; Oleg A Melnikov; Ludmila M Antonenko; Elena E Sigaleva; Maksym I Situkho; Olena I Asaulenko; Vasyl I Popovych; Maxim V Zamergrad
Journal:  PLoS One       Date:  2017-03-30       Impact factor: 3.240

6.  Betahistine add-on therapy for treatment of subjects with posterior benign paroxysmal positional vertigo: a randomized controlled trial.

Authors:  Ibrahim Sayin; Recep Haydar Koç; Dastan Temirbekov; Selcuk Gunes; Musa Cirak; Zahide Mine Yazici
Journal:  Braz J Otorhinolaryngol       Date:  2020-09-12

7.  Effectiveness of the Epley's maneuver performed in primary care to treat posterior canal benign paroxysmal positional vertigo: study protocol for a randomized controlled trial.

Authors:  José Luis Ballve Moreno; Ricard Carrillo Muñoz; Iván Villar Balboa; Yolanda Rando Matos; Olga Lucia Arias Agudelo; Asha Vasudeva; Olga Bigas Aguilera; Jesús Almeda Ortega; Alicia Capella Guillén; Clara Johanna Buitrago Olaya; Xavier Monteverde Curto; Estrella Rodero Perez; Carles Rubio Ripollès; Pamela Catalina Sepulveda Palacios; Noemí Moreno Farres; Anabella María Hernández Sánchez; Carlos Martin Cantera; Rafael Azagra Ledesma
Journal:  Trials       Date:  2014-05-21       Impact factor: 2.279

8.  Efficacy of Epley's Maneuver in Treating BPPV Patients: A Prospective Observational Study.

Authors:  Sushil Gaur; Sanjeev Kumar Awasthi; Sunil Kumar Singh Bhadouriya; Rohit Saxena; Vivek Kumar Pathak; Mamta Bisht
Journal:  Int J Otolaryngol       Date:  2015-10-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.